GREY:IPHAF - Post by User
Comment by
wrongturnon Apr 04, 2009 2:27am
752 Views
Post# 15896547
RE: A comment about Novartis
RE: A comment about NovartisSo the eye ball indication hits the market later this year with Lux?
Psoarisis, as it is de-risked and hopefully approved by the FDA et al next year, Novartis comes in as a partner? And if not approved by the FDA.......then no partner?
So the vultures wait to see how ISA does as a company. If it is able to carry its own weight until later next year and hopefully bring psoarisis to market, at that point a partner comes in, congratulates ISA for surviving, and proposes a deal?
Doesn't Novartis own 30% of Roche or vice versa? So as long as 1 can't cash in, the other can smash the crap out of a company and the sister cashes in? Working with large pharma, damned if you do and damned if you don't.
I wonder if Novartis will try to hold back psoarisis until 2013 with tx? But why would they if voclo is already on the market with uveitis?
I would appreciate anybody's comments on when the patent clock(s) start to tick?